RHYTHM PHARMACEUTICALS, INC.

By person

15 insiders · 57 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lee Jennifer Kayden

EVP, Head of North America

—

$8.90M (1) scheduled

−$8.90M

0.0000%

$0.00

−100.0%

Smith Hunter C

Chief Financial Officer

—

$8.84M (26) scheduled

−$8.84M

114,024

0.1656%

$11.99M

+16.4%

Mazabraud Yann

EVP, Head of International

—

$6.62M (6) scheduled

−$6.62M

55,655

0.0808%

$5.85M

+59.6%

Meeker David P

President and CEO

—

$5.13M (5) scheduled

−$5.13M

239,258

0.3475%

$25.17M

+32.3%

TETRAULT LYNN A.

Director

—

$3.71M (1) scheduled

−$3.71M

11,712

0.0170%

$1.23M

+290.4%

Shulman Joseph

Chief Technical Officer

—

$3.67M (6) scheduled

−$3.67M

15,915

0.0231%

$1.67M

—

Cramer Pamela J.

Chief Human Resources Officer

—

$2.99M (4) scheduled

−$2.99M

29,376

0.0427%

$3.09M

+117.6%

German Christopher Paul

Corporate Controller & CAO

—

$930.92K (2) scheduled

−$930.92K

0.0000%

$0.00

−100.0%

Garfield Alastair

Chief Scientific Officer

—

$912.70K (4) scheduled

−$912.70K

2,295

0.0033%

$241.41K

—

Mathers Edward T

Director

—

21,168

0.0307%

$2.23M

+141.3%

Arbuckle Stuart A

Director

—

11,712

0.0170%

$1.23M

+290.4%

MCGIRR DAVID W J

Director

—

11,712

0.0170%

$1.23M

+290.4%

JEAN CHRISTOPHE

Director

—

11,712

0.0170%

$1.23M

+290.4%

GOOD JENNIFER L

Director

—

11,712

0.0170%

$1.23M

+290.4%

Bedrosian Camille L

Director

—

7,000

0.0102%

$736.33K

+133.3%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

800

$119.17

$95.34K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

3,400

$118.28

$402.17K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

1,556

$117.08

$182.17K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

2,007

$116.11

$233.03K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

585

$103.28

$60.42K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

800

$102.10

$81.68K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

1,692

$100.92

$170.75K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

1,308

$100.27

$131.15K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

200

$103.84

$20.77K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

1,069

$103.00

$110.11K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

900

$101.70

$91.53K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

200

$100.52

$20.10K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

1,200

$99.42

$119.30K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

100

$100.10

$10.01K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

800

$98.99

$79.19K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

400

$97.67

$39.07K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

292

$96.26

$28.11K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

100

$100.85

$10.09K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

400

$99.44

$39.77K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

2,266

$98.37

$222.91K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

100

$104.76

$10.48K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

700

$103.68

$72.57K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

1,913

$102.66

$196.38K

Smith Hunter C

5 Feb 2026

Chief Financial Officer

Sold on a plan

3,381

$106.06

$358.60K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

747

$107.67

$80.43K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

1,000

$106.60

$106.60K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

1,500

$104.74

$157.12K

Show all 57 transactions →

RHYTHM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out